Larimar Therapeutics, Inc.
$1.99
-0.00 (-0.25%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -47.8%
- 3 Months
- -48.2%
- YTD
- -47.9%
- 1 Year
- -53.2%
- 3 Year annualized
- -13.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 98.6%
- Largest decline max drawdown, since Oct 2021
- -88.6%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.34
Own LRMR?
See how LRMR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.